Lozano-García, Omar

Omar Lozano graduated with honors as an Industrial Physics Engineer from Tecnológico de Monterrey in 2004, a Master of Science in Physics from the University of Houston in 2006, a PhD in Physics from the University of Houston in 2009, and a Master of Management from the University of Namur in 2015 (honor). He was a postdoctoral researcher at the University of Namur from 2010 to 2015 in nanotoxicology/nanosafety, and at Tecnológico de Monterrey from 2015 to 2018 in nanomedicine and nanotoxicology. Currently, at Tecnológico de Monterrey, he is an associate professor and researcher at the School of Medicine and Health Sciences and the Institute for Obesity Research (IOR), and leader of the Bioengineering and Medical Devices unit at the IOR. His research focuses on: 1) developing nanosystems for the efficient transport of molecules in cardiometabolic diseases, 2) delivering therapeutic and diagnostic compounds, and 3) nanobiointeractions and nanosafety/nanotoxicology in cardiometabolic diseases. He has 63 publications (h-index: 22), 5 patents, and 2 book chapters. He is a member of the National System of Researchers (SNII) Level 2 of the SECIHTI (Mexico) and Chargé de Recherche (Belgium). He is a co-founder of Nano 4 Heart, S.C., a company dedicated to accelerating the development of next-generation drugs for the treatment of cardiovascular diseases; and of Naddon, a spin-off that uses nanotechnology for the treatment of chronic diseases at specific sites.